Literature DB >> 2512742

Adenocarcinoma and carcinoid developing spontaneously in the stomach of mutant strains of Mastomys natalensis.

H Kumazawa1, H Takagi, K Sudo, W Nakamura, S Hosoda.   

Abstract

Neoplastic and nonneoplastic lesions developing spontaneously in antral and fundic mucosae of stomachs of mutant chamois-coloured Z (130 animals) and Y (67 animals) strains of Mastomys aged 18 to 24 months were examined histologically and histochemically. The Z strain developed both antral lesions (hyperplasia 29.2%; dysplasia 23.8%; adenocarcinoma 17.7%) and fundic carcinoid(s) (72.3%). The antral lesions were limited to the lesser curvature near the pyloric ring. Macroscopically, adenocarcinomas resembled human gastric carcinomas of either Borrmann's type I or II. Histochemically, adenocarcinoma cells were characterised by marked reduction of total mucins produced and predominance of mucins with both periodic acid-Schiff and Alcian blue reactivities (neutral and sialated class II mucins). An infiltrating adenocarcinoma was successfully transplanted into nude mice, reaching the 7th generation of transplantations over 4 years, and retained histological features of the primary tumour. The ultrastructural appearance of growing transplanted tumours supported the reduced production of mucins by adenocarcinoma cells with scarcity of mucin granules and intracellular cysts. However, the Y strain never developed antral lesions like the wild strain, developing fundic carcinoid(s) only. Microscopically, these carcinoids contained argyrophilic nonargentaffin granules, and biochemically produced histamine consistently but no 5-hydroxytryptamine (5-HT, serotonin) like those of the wild strain. Since we found unexpectedly that a line of F2 but not F1 hybrids between wild and Z strains developed the same antral lesions as Z strain, a preliminary experiment was performed to confirm the development of antral lesions in F2 hybrids newly produced by brother-sister mating. Among 41 surviving F2 offspring, 4 (9.8%) developed hyperplasia, 2 (4.9%) dysplasia and none adenocarcinoma. The numbers (6) of animals observed with these lesions approximated to their expected numbers (7.3).

Entities:  

Mesh:

Year:  1989        PMID: 2512742     DOI: 10.1007/bf01606319

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  14 in total

1.  Animal model: carcinoids and adenocarcinoma of the glandular stomach of Praomys (Mastomys) natalensis.

Authors:  J D Randeria
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

2.  Histidine decarboxylase in the transplantable argyrophilic gastric carcinoid of Praomys (Mastomys) natalensis.

Authors:  S Hosoda; W Nakamura; K C Snell; H L Stewart
Journal:  Biochem Pharmacol       Date:  1971-10       Impact factor: 5.858

3.  Occult blood appearance in feces and tissue hemorrhages in mice after whole body x-irradiation.

Authors:  W Nakamura; T Kankura; H Eto
Journal:  Radiat Res       Date:  1971-10       Impact factor: 2.841

4.  Histochemical and proliferative changes preceding the onset of spontaneous gastric adenocarcinoma in Mastomys natalensis.

Authors:  Y Tielemans; T Vierendeels; G Willems
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Carcinoids and adenocarcinoma of the glandular stomach in Praomys (Mastomys) natalensis treated with 3-methylcholanthrene.

Authors:  J D Randeria
Journal:  Gan       Date:  1980-04

6.  Histamine production by transplantable argyrophilic gastric carcinoid of Praomys (Mastomys) natalensis.

Authors:  S Hosoda; W Nakamura; K C Snell; H L Stewart
Journal:  Science       Date:  1970-10-23       Impact factor: 47.728

7.  Histochemical differentiation of complex carbohydrates with variants of the concanavalin A-horseradish peroxidase method.

Authors:  T Katsuyama; S S Spicer
Journal:  J Histochem Cytochem       Date:  1978-04       Impact factor: 2.479

8.  Precancerous conditions and epithelial dysplasia in the stomach.

Authors:  B C Morson; L H Sobin; E Grundmann; A Johansen; T Nagayo; A Serck-Hanssen
Journal:  J Clin Pathol       Date:  1980-08       Impact factor: 3.411

9.  Malignant argyrophilic gastric carcinoids of Praomys (Mastomys) natalensis.

Authors:  K C Snell; H L Stewart
Journal:  Science       Date:  1969-01-31       Impact factor: 47.728

Review 10.  Recessive mechanisms of malignancy.

Authors:  A R Green
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

View more
  7 in total

1.  Observations on relationship between hypergastrinemia, multiple gastric carcinoids, and pancreatic mass.

Authors:  I M Modlin; C J Gilligan; G P Lawton; L H Tang; A B West; R Lindenberg
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

2.  Rapid induction of enterochromaffinlike cell tumors by histamine2-receptor blockade.

Authors:  O Nilsson; B Wängberg; L Johansson; E Theodorsson; A Dahlström; I M Modlin; H Ahlman
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

Review 3.  Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays.

Authors:  Sundeep A Chandra; Michael W Nolan; David E Malarkey
Journal:  Toxicol Pathol       Date:  2009-12-17       Impact factor: 1.902

Review 4.  Histamine metabolism of gastric carcinoids in Mastomys natalensis.

Authors:  L Kölby; B Wängberg; H Ahlman; I M Modlin; O Nilsson
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 5.  Mouse models of gastric carcinogenesis.

Authors:  Sungsook Yu; Mijeong Yang; Ki Taek Nam
Journal:  J Gastric Cancer       Date:  2014-06-30       Impact factor: 3.720

Review 6.  Praomys (Mastomys) natalensis: a model for gastric carcinoid formation.

Authors:  O Nilsson; B Wängberg; L Johansson; I M Modlin; H Ahlman
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec

7.  Mouse models of gastric cancer.

Authors:  Yoku Hayakawa; James G Fox; Tamas Gonda; Daniel L Worthley; Sureshkumar Muthupalani; Timothy C Wang
Journal:  Cancers (Basel)       Date:  2013-01-24       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.